PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.
Timothy Squire of Fasken Martineau was retained by a US based manufacturer of recombinant human glycoprotein to assist with their clinical trial program and market authorization, including protocol, agreements, classification and submission.